0000000000165080

AUTHOR

Maurizio Bevilacqua

showing 13 related works from this author

Intermittent intramuscular clodronate therapy: a valuable option for older osteoporotic women

2005

Agingmedicine.medical_specialtyOsteoporosisTreatment outcomeMEDLINE.Injections IntramuscularDrug Administration Schedulelaw.inventionPhysical medicine and rehabilitationPharmacotherapyRandomized controlled triallawBone DensitymedicineHumansFemurVitamin DOsteoporosis PostmenopausalAgedPain MeasurementLumbar Vertebraecalcium clodronic acid vitamin DBone Density Conservation Agentsbusiness.industryGeneral Medicinemedicine.diseaseTreatment OutcomeBack PainPhysical therapyCalciumDrug Therapy CombinationFemaleGeriatrics and GerontologyClodronic Acidbusiness
researchProduct

Increased Gastrin and Calcitonin Secretion after Oral Calcium or Peptones Administration in Patients with Hypercalciuria: A Clue to an Alteration in …

2005

The calcium-sensing receptor (CaSR) has been detected in human antral gastrin-secreting cells, where, upon calcium and/or amino acid allosteric activation, it stimulates gastrin secretion. Patients with absorptive hypercalciuria (AH) display an enhanced gastric acid output; therefore, we evaluated the secretion of gastrin in subjects with AH ( 30 subjects vs. 30 healthy female controls, all postmenopausal) after oral calcium administration ( 1 g calcium gluconate) and, on a separate occasion, after peptone loading test ( protein hydrolyzed, 10 g). Gastrin and monomeric calcitonin responses were higher in AH after both oral calcium administration ( P < 0.01) and peptone loading ( P< 0.01). B…

Calcitoninmedicine.medical_specialtyEndocrinology Diabetes and MetabolismClinical BiochemistryThyroid GlandAdministration Oralchemistry.chemical_element.CalciumBiochemistryKidney CalculiEndocrinologyOral administrationCalcium Metabolism DisordersInternal medicineGastrinsmedicineHumansGastrin-Secreting CellsHypercalciuriaAgedGastrinBiochemistry (medical)Middle AgedCalcitonin secretionmedicine.diseaseCalcium GluconateEndocrinologychemistryGastrointestinal hormoneParathyroid HormoneCalcitoninPeptonesFemaleCalcium-sensing receptorReceptors Calcium-Sensinghormones hormone substitutes and hormone antagonistsThe Journal of Clinical Endocrinology &amp; Metabolism
researchProduct

Effects of fluvastatin slow-release (XL 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes.

2005

The lipid triad is the association of small, dense (sd) low-density lipoprotein (LDL), low high-density lipoprotein (HDL), and hypertriglyceridemia, all of which play a role in coronary artery disease in patients with type 2 diabetes. Although statins have demonstrated clear positive effects on cardiovascular morbidity/mortality in patients with diabetes and on single components of the lipid triad, it remains controversial whether they affect all components of the triad in these patients. Therefore, we performed a single-center, parallel-group, prospective, randomized, open-label, blinded-endpoint (PROBE)-type comparison of fluvastatin extended-release (XL) 80 mg (n=48) and simvastatin 20 m…

Malemedicine.medical_specialtySimvastatinIndolesHDLApolipoprotein BSmall dense LDLType 2 diabetesTriglycerideLDLFatty Acids MonounsaturatedFluvastatin XLInternal medicineDiabetes mellitusType 2 diabetes mellitusmedicineHumansPharmacology (medical)Prospective StudiesFluvastatinAgedHypertriglyceridemiabiologybusiness.industryAnticholesteremic AgentsApoA-IHypertriglyceridemianutritional and metabolic diseasesType 2 Diabetes MellitusGeneral MedicineMiddle Agedmedicine.diseaseLipoproteins LDLEndocrinologyDiabetes Mellitus Type 2SimvastatinDelayed-Action Preparationsbiology.proteinlipids (amino acids peptides and proteins)FemaleApoBbusinessLipoproteins HDLFluvastatinmedicine.drugLipoproteinAdvances in therapy
researchProduct

Vitamin D substrate-product relationship in idiopathic hypercalciuria.

2007

Absorptive hypercalciuria (AH) is associated with elevated levels of 1,25-dihydroxyvitamin D (1,25(OH)(2)D). While no increase of 1,25(OH)(2)D after oral administration of 25-hydroxyvitamin D (25OHD) at high doses has been claimed in normal subjects, a substrate-product relationship has been reported in normal children, young people after UV irradiation, older persons, postmenopausal women, primary hyperparathyroidism, renal failure, osteomalacia, and sarcoidosis. No data of this relationship in AH is available. To investigate 25OHD-1,25(OH)(2)D substrate-product relationship in AH, 161 AH patients (mean age 60.9+/-11.7 years) and 110 age- and sex-matched controls (mean age 61.5+/-12.4 year…

Malemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryHypercalciuriaAdministration OralBiochemistryBasal (phylogenetics)EndocrinologyOral administrationInternal medicinemedicineVitamin D and neurologyHumansHypercalciuriaVitamin DMolecular BiologyAgedKidneyOsteomalaciaChemistryCell BiologyMiddle Agedmedicine.diseaseSteroid hormoneEndocrinologymedicine.anatomical_structureCase-Control StudiesMolecular MedicineFemaleSeasonsPrimary hyperparathyroidismThe Journal of steroid biochemistry and molecular biology
researchProduct

Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors

2002

In order to evaluate the prevalence, risk factors, and clinical consequences of hypovitaminosis D in elderly Italian women a multicenter study of 43 osteoporosis centers from all regions of Italy was carried out. Study population included 700 women aged 60-80 years in whom blood was taken for 25-hydroxyvitamin D (25OHD) and parathyroid hormone (PTH) measurements. All subjects were also questioned to assess the prevalence of several risk factors for hypovitaminosis D, osteoporotic fractures and activities of daily living (ADL). Values of 25OHD lower than 5 ng/ml were found in 27% of the women and lower than 12 ng/ml in 76%. 25OHD and PTH levels were negatively correlated ( r=-0.38, after log…

medicine.medical_specialtyActivities of daily livingEndocrinology Diabetes and MetabolismOsteoporosisPopulationvitamin D deficiencyRisk FactorsPrevalencemedicineVitamin D and neurologyHumansRisk factoreducationAged25-Hydroxyvitamin D 2Aged 80 and overHip fractureeducation.field_of_studybusiness.industrySmokingMiddle AgedVitamin D Deficiencymedicine.diseaseDietItalyParathyroid HormonePhysical therapyEducational StatusPopulation studyFemaleDairy ProductsbusinessDemographyOsteoporosis International
researchProduct

Insulin Resistance and the Cardiometabolic Syndrome in HIV Infection

2009

Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of HIV-positive patients. However, long-term adverse effects of this therapy include dyslipidemia, insulin resistance (IR), changes in body fat distribution (lipodystrophy), and cardiometabolic syndrome (CMS). IR in HIV-positive patients does not seem to represent a significant independent risk factor for the development of cardiovascular disease; nevertheless, the association with other metabolic complications (dyslipidemia, fat redistribution) and CMS may increase the risk of type 2 diabetes and cardiovascular disease. The use of nucleoside analogue reverse transcriptase inhibitors is associated with the …

medicine.medical_specialtyEndocrinology Diabetes and MetabolismHIV InfectionsType 2 diabetesGastroenterologyInsulin resistanceAntiretroviral Therapy Highly ActiveDiabetes mellitusInternal medicineInternal MedicinemedicineHumansRisk factorMetabolic Syndromebusiness.industrymedicine.diseaseMetforminEndocrinologyCardiovascular DiseasesInsulin ResistanceLipodystrophyCardiology and Cardiovascular MedicinebusinessRosiglitazoneDyslipidemiamedicine.drugJournal of the CardioMetabolic Syndrome
researchProduct

Dissimilar PTH, Gastrin, and Calcitonin Responses to Oral Calcium and Peptones in Hypocalciuric Hypercalcemia, Primary Hyperparathyroidism, and Norma…

2005

We analyzed gastrin, PTH, and calcitonin responses to oral calcium and peptones in hypocalciuric hypercalcemia, mild primary hyperparathyroidism, and normal controls. We observed diverse hormonal responses that may help in the differential diagnosis of these conditions. Introduction: Hypocalciuric hypercalcemia (HH) is consequent to calcium-sensing receptor (CaSR) genetic mutations or anti-CaSR antibodies. CaSR is expressed in parathyroid tissue, thyroid C cells, and gastrin-secreting cells, where it has been suggested that on calcium and/or amino acid allosteric activation, promotes gastrin secretion. Materials and Methods: We evaluated gastrin, PTH, and calcitonin responses to oral calciu…

CalcitoninMalemedicine.medical_specialtyPeptide HormonesEndocrinology Diabetes and Metabolismchemistry.chemical_elementParathyroid hormoneCalciumDiagnosis DifferentialInternal medicineGastrinsmedicineHumansOrthopedics and Sports MedicineAgedGastrinHyperparathyroidismHypocalcemiaFamilial hypocalciuric hypercalcemiabusiness.industryHyperparathyroidismMiddle Agedmedicine.diseaseEndocrinologychemistryParathyroid HormoneCalcitoninPeptonesCalciumFemaleCalcium-sensing receptorbusinesshormones hormone substitutes and hormone antagonistsPrimary hyperparathyroidismJournal of Bone and Mineral Research
researchProduct

Diagnosing and Managing Thyroid Disease in the Nursing Home

2007

Thyroid disorders occur at any age, but hypothyroidism is more common in older than in younger adults. In fact, the prevalence of thyroid disorders increases with age, and it is higher in old-old frail residents in nursing homes. Since thyroid diseases in older age, both overt reduced and increased function, may manifest as disorders of other organs, physicians need a high index of suspicion to detect thyroid dysfunction in an older person with multiple comorbidities and chronic polypharmacy. This is particularly true for residents of long-term facilities, where multiple chronic diseases may make it less attractive to direct attention to thyroid function. Subclinical hyperthyroidism and hyp…

MaleAgingendocrine systemmedicine.medical_specialtyPediatricsendocrine system diseasesMEDLINEQuality of lifeInternal medicinePrevalenceHomes for the AgedHumansMedicineGeneral NursingSubclinical infectionAged 80 and overPolypharmacybusiness.industryHealth PolicyThyroid diseaseThyroidGeneral Medicinemedicine.diseaseLong-Term CareThyroid DiseasesNursing HomesLong-term caremedicine.anatomical_structureEndocrinologyFemaleGeriatrics and GerontologyThyroid functionbusinessJournal of the American Medical Directors Association
researchProduct

Acute parathyroid hormone increase by oral peptones administration after roux-en-Y gastric bypass surgery in obese subjects: Role of phosphate in the…

2010

It is generally considered that changes in serum phosphate levels do not alter parathyroid hormone (PTH) secretion in the absence of concomitant changes in ionized serum calcium level in humans. An acute rise in PTH was shown after phosphate administration by intraduodenal gavage in rats. We aimed to study gastrin, phosphate, PTH, ionized calcium (iCa), and blood pH responses to oral peptones in morbidly obese patients before and after roux-en-Y gastric bypass (RYGB) surgery.These parameters were evaluated in response to an oral peptone load in 24 (18 male and 6 female) obese subjects before and 6 months after RYGB surgery. In 12 gastric bypass patients, we also evaluated PTH and phosphate …

AdultMalemedicine.medical_specialtyGastric BypassAdministration OralParathyroid hormonechemistry.chemical_elementAluminum HydroxideCalciumgastric bypass phosphate parathyroid hormone ionized calcium peptonesmedicine.disease_causePhosphatesJejunumYoung Adultchemistry.chemical_compoundInternal medicineGastrinsmedicineHumansPostoperative PeriodProspective StudiesGastrinCalcium metabolismGastrointestinal tractGastric bypass surgerybusiness.industryHydrogen-Ion ConcentrationPhosphateObesity MorbidJejunumEndocrinologymedicine.anatomical_structureIntestinal AbsorptionchemistryParathyroid HormonePeptonesCalciumFemaleSurgerybusinesshormones hormone substitutes and hormone antagonistsSurgery
researchProduct

Prediction of bone mass gain by bone turnover parameters after parathyroidectomy for primary hyperparathyroidism: neural network software statistical…

2006

Background Primary hyperparathyroidism (pHPT) is the most frequent endocrine hypersecretion disease, and parathyroidectomy is the only curative option, since pharmacologic therapy reduces hypercalcemia but does not impede parathyroid hormone hypersecretion. According to guidelines from the National Institutes of Health, parathyroidectomy is associated with bone mass increase in some asymptomatic patients, while in others bone mass is not changed after surgery. Therefore, we performed the present study in an attempt to elucidate whether a preoperative biochemical bone parameter can be predictive of a significant vertebral bone mass increase in patients with pHPT. Methods For each patient we …

Parathyroidectomymedicine.medical_specialtymedicine.medical_treatmentUrinary systemUrologyParathyroid hormoneCollagen Type Ibone mass bone mineralization bone turnoverBone remodelingBone DensityHumansMedicineAgedAged 80 and overParathyroidectomyHyperparathyroidismbiologybusiness.industryMiddle AgedHyperparathyroidism Primarymedicine.diseaseUrinary calciumSurgeryOsteocalcinbiology.proteinSurgeryBone RemodelingNeural Networks ComputerPeptidesbusinessPrimary hyperparathyroidismSurgery
researchProduct

Induction of vascular endothelial growth factor release by transcutaneous frequency modulated neural stimulation in diabetic polyneuropathy

2008

Background: Pharmacological treatment for diabetic polyneuropathy (DP) has shown limited benefit; frequency-modulated electrical stimulation (FREMS) has shown positive results in pain control and nerve conduction velocity in DP. Objective: To investigate the effects of FREMS vs transcutaneous electrical nerve stimulation (TENS) on the release of vascular endothelial growth factor (VEGF) in Type 2 diabetic and in non-diabetic subjects. Methods: 10 non-diabetic [mean age 37±5 yr; females (F)/males (M): 6/4] and 10 Type 2 diabetic subjects (mean age 52±6 yr; F/M: 5/5) with DP underwent TENS (for 10 min) followed by 30 min interval without electrical stimulation, and then FREMS (for 10 min) ove…

AdultMaleVascular Endothelial Growth Factor Amedicine.medical_specialtyDiabetic neuropathyEndocrinology Diabetes and MetabolismNeural ConductionAction PotentialsPainElectric Stimulation TherapyStimulationTranscutaneous electrical nerve stimulationNerve conduction velocitylaw.inventionchemistry.chemical_compoundEndocrinologyDiabetic NeuropathiesForearmlawInternal medicineVasa nervorumHumansPain ManagementMedicineMotor Neuronsbusiness.industryMicroangiopathyMiddle Agedmedicine.diseaseVascular endothelial growth factorEndocrinologymedicine.anatomical_structurechemistryTranscutaneous Electric Nerve StimulationFemalebusiness
researchProduct

How was the Turin Shroud Man crucified?

2014

As the literature is not exhaustive with reference to the way the Turin Shroud (TS) Man was crucified, and it is not easy to draw significant information from only a "photograph" of a man on a linen sheet, this study tries to add some detail on this issue based on both image processing of high resolution photos of the TS and on experimental tests on arms and legs of human cadavers. With regard to the TS Man hands, a first hypothesis states that the left hand of the TS Man was nailed twice at two different anatomical sites: the midcarpal joint medially to the pisiform between the lunate/pyramidal and capitate/uncinate bones (Destot's space) and the radiocarpal joint between the radio, lunate…

Wrist JointFamous PersonsMyocardial InfarctionPoison controlSettore MED/33 - Malattie Apparato LocomotoreShock TraumaticOrthopedics and Sports MedicineUlnar nerveForensic PathologyHistory AncientGeneral Environmental Scienceintegumentary systemMedicine (all)ContusionBiomechanical Phenomenamedicine.anatomical_structureMidcarpal jointNail (anatomy)Emergency MedicineTurin Shroud ManHomicideHumanmedicine.medical_specialtyCausalgiaContusionsTortureCause of deathViolenceChristianityAsphyxiaImmobilizationmedicineCadaverHumansCrucifixion techniquebusiness.industryFootWounds and InjurieFamous PersonMetacarpophalangeal jointHandSurgerybody regionsLunateTarsal BoneWounds and InjuriesGeneral Earth and Planetary SciencesForensic AnthropologyAnkleNailingbusiness
researchProduct

Bisphosphonates and atherosclerosis: why?

2005

The increasing knowledge on bone calcification processes has revealed some similarities with vascular tissue, where calcifications of arteries and cardiac valves contribute to several cardiovascular problems, such as heart failure, systolic hypertension, and myocardial and peripheral ischemic disease. Bisphosphonates have been used extensively for over two decades for the treatment of diseases associated with excessive bone resorption, i.e., osteoporosis, osteolytic bone metastasis, hypercalcemia and Paget’s disease, by blocking osteoclastic function. Etidronate, pamidronate and clodronate has been shown to inhibit the development of experimental atherosclerosis, and proposed mechanisms fo…

medicine.medical_specialtyOsteoporosisMevalonic AcidApoptosisDisease030204 cardiovascular system & hematologyBone resorption03 medical and health sciences0302 clinical medicineRheumatologyCalcinosisInternal medicinemedicineHumansBone ResorptionFoam cell030203 arthritis & rheumatologyDiphosphonatesMolecular Structurebusiness.industryMacrophagesBone metastasisCalcinosismedicine.diseaseAtherosclerosisArterial calcificationEndocrinologyCholesterolHeart failureCancer researchbusinessLupus
researchProduct